glp 1 ncbi Peptide sequences and molecular structures of FDA approved GLP-1 RAs GLP-1 Analogues in the Neurobiology

Rubino, P

10.1002/ijc.23131 22 MotzerR

HosieAMWilkinsMEda SilvaHMSmartTG

They found that glutathione peroxidase activity is robustly protective in these models of Huntingtons disease

Currently, there are ten classes of orally available pharmacological agents to treat T2DM: 1) sulfonylureas (SU), 2) meglitinides, 3) metformin (a biguanide), 4) thiazolidinediones (TZDs), 5) alpha glucosidase inhibitors, 6) dipeptidyl peptidase IV (DPP-4) inhibitors, 7) bile acid sequestrants, 8) dopamine agonists, 9) sodium-glucose transport protein 2 (SGLT2) inhibitors and 10) oral glucagon like peptide 1 (GLP-1) receptor agonists (6-8)